Influences of sex on gene expression discussed at annual conference

November 19, 2002

New discoveries on the interplay between genes and biological sex were the topic of discussions at the Third Annual Conference on Sex and Gene Expression (SAGE III), hosted by the Society for Women's Health Research, in San Jose, CA, April 4-7, 2002. The annual conference is a unique interdisciplinary forum for basic research scientists to share data and explore the frontiers of how biological sex influences the expression of genetic information throughout life, from embryonic development through adulthood. Leading established researchers and outstanding new researchers in biochemistry, genetics and molecular, developmental and cellular biology attended the by-invitation-only meeting. A report from SAGE III is available by contacting Jennifer Brindise at (202) 496-5015 or Jen@womens-health.org.

Highlights of the first panel, which covered model systems for understanding sex differences in development, included a discussion of the genetic regulation of sex determination in fruit flies and nematodes as well as the contributions of genes on the X and Y chromosomes to brain development in birds and rodents.

Discussion on sex and gene expression in the immune system included the effect of fetal cells remaining in maternal circulation, termed microchimerism, and the role of these fetal cells in the development of autoimmune diseases. The effects of sex steroid hormones - estrogen, progesterone and testosterone - on the development and progression of autoimmune diseases were also discussed. Caroline Whitacre, PhD, of Ohio State University, discussed the beneficial effect of pregnancy on the clinical course of multiple sclerosis, an autoimmune disease that affects women two to three times more than men.

Sex hormones play a role in the development and progression of prostate and breast cancers. Despite diverse genetic and environmental factors contributing to prostrate and breast cancer, Diane Robins, PhD, University of Michigan Medical School, explained that both tumors initially are steroid hormone dependent. Hormonal aspects of bone formation and the development of dry eye syndromes were also discussed.

Workshops and poster presentations rounded out the meeting, allowing most participants to present their research.
-end-
To order a copy of the SAGE report, contact Jennifer Brindise at Jen@womens-health.org or (202) 496-5015.

Society for Women's Health Research

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.